Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Atkinson

Showing results (21-30 of 126) with videos related to

Pageof 13
Sort By:
The Lancet. Oncology|August 14, 2018
Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation - Authors' replyGeorgina V Long, Victoria Atkinson, Angela Hong, et al.
International Surgery|January 17, 2015
Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis secondary to mucinous adenocarcinoma of the appendixDavid S Sparks, Bradley Morris, Wen Xu, et al.
Internal Medicine Journal|January 9, 2025
Comparative study of management strategies for immune checkpoint inhibitor-induced inflammatory arthritis: rheumatologists versus oncologistsJang S Yoon, Frances Zhao, Hafsa Masood, et al.
Journal for Immunotherapy of Cancer|November 21, 2020
Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanomaVictoria Atkinson, Adnan Khattak, Andrew Haydon, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 5, 2002
Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over studyLana Dépatie, Gillian A O'Driscoll, Anne-Lise V Holahan, et al.
BMC Nephrology|September 7, 2020
Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series reportSebastian Hultin, Kazi Nahar, Alexander M Menzies, et al.
BMJ Open|September 17, 2021
Protocol for implementation of the 'AusPROM' recommendations for elective surgery patients: a mixed-methods cohort studyMeg E Morris, Natasha Brusco, Jeffrey Woods, et al.
Journal of Patient-Reported Outcomes|July 7, 2022
Implementing PROMS for elective surgery patients: feasibility, response rate, degree of recovery and patient acceptabilityNatasha K Brusco, Victoria Atkinson, Jeffrey Woods, et al.
Cancers|June 10, 2022
In-Depth Characterisation of Real-World Advanced Melanoma Patients Receiving Immunotherapies and/or Targeted Therapies: A Case SeriesSaira Sanjida, Brigid Betz-Stablein, Victoria Atkinson, et al.
ANZ Journal of Surgery|July 21, 2021
Contemporary management of locoregionally advanced melanoma in Australia and New Zealand and the role of adjuvant systemic therapyB Mark Smithers, Robyn P M Saw, David E Gyorki, et al.
Pageof 13

Showing results (21-30 of 126) with videos related to

Sort By:
Pageof 13
The Lancet. Oncology|August 14, 2018
Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation - Authors' replyGeorgina V Long, Victoria Atkinson, Angela Hong, et al.
International Surgery|January 17, 2015
Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis secondary to mucinous adenocarcinoma of the appendixDavid S Sparks, Bradley Morris, Wen Xu, et al.
Internal Medicine Journal|January 9, 2025
Comparative study of management strategies for immune checkpoint inhibitor-induced inflammatory arthritis: rheumatologists versus oncologistsJang S Yoon, Frances Zhao, Hafsa Masood, et al.
Journal for Immunotherapy of Cancer|November 21, 2020
Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanomaVictoria Atkinson, Adnan Khattak, Andrew Haydon, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 5, 2002
Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over studyLana Dépatie, Gillian A O'Driscoll, Anne-Lise V Holahan, et al.
BMC Nephrology|September 7, 2020
Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series reportSebastian Hultin, Kazi Nahar, Alexander M Menzies, et al.
BMJ Open|September 17, 2021
Protocol for implementation of the 'AusPROM' recommendations for elective surgery patients: a mixed-methods cohort studyMeg E Morris, Natasha Brusco, Jeffrey Woods, et al.
Journal of Patient-Reported Outcomes|July 7, 2022
Implementing PROMS for elective surgery patients: feasibility, response rate, degree of recovery and patient acceptabilityNatasha K Brusco, Victoria Atkinson, Jeffrey Woods, et al.
Cancers|June 10, 2022
In-Depth Characterisation of Real-World Advanced Melanoma Patients Receiving Immunotherapies and/or Targeted Therapies: A Case SeriesSaira Sanjida, Brigid Betz-Stablein, Victoria Atkinson, et al.
ANZ Journal of Surgery|July 21, 2021
Contemporary management of locoregionally advanced melanoma in Australia and New Zealand and the role of adjuvant systemic therapyB Mark Smithers, Robyn P M Saw, David E Gyorki, et al.
Pageof 13